{"id":59176,"date":"2014-05-01T00:00:00","date_gmt":"2018-12-04T07:17:58","guid":{"rendered":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/"},"modified":"2018-12-04T08:17:58","modified_gmt":"2018-12-04T07:17:58","slug":"what-should-we-tell-prostate-cancer-patients-about-secondary","status":"publish","type":"resume","link":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/","title":{"rendered":"What should we tell prostate cancer patients about (secondary) prevention?"},"content":{"rendered":"<p><strong>PURPOSE OF REVIEW<\/strong><br \/>\nTo briefly summarize the epidemiologic findings of selected lifestyle factors for prostate cancer progression, metastasis, or death, with a focus on behaviors after diagnosis where possible. We conclude by providing guidance on the lifestyle practices that physicians may wish to prioritize for discussion with their patients.<\/p>\n<p><strong>RECENT FINDINGS<\/strong><br \/>\nGrowing, but still limited, evidence suggests that lifestyle factors after prostate cancer diagnosis may impact prostate-cancer-specific and overall morality. In particular, smoking and obesity may increase the risk of disease progression and mortality, whereas engaging in vigorous physical activity or brisk walking and consuming a diet rich in vegetables (particularly tomato sauce and cruciferous) and vegetable fats may lower the risk.<\/p>\n<p><strong>SUMMARY<\/strong><br \/>\nPatients should be counseled not to use tobacco products; to engage in daily physical activity; to minimize sedentary behavior; to consume plenty of healthy fats (i.e. fish, nuts, vegetable oils, soybeans, avocados, and flaxseed) and vegetables; to focus on getting nutrients from foods rather than supplements; and to limit refined grains, sugars, processed meat, and high-fat dairy.<\/p>\n","protected":false},"template":"","mots_cles":[],"class_list":["post-59176","resume","type-resume","status-publish","hentry"],"acf":{"adresse":"Department of Epidemiology and Biostatistics bDepartment of Urology, University of California, San Francisco, San Francisco, California, USA.\r\nJune.Chan@ucsf.edu","annee":"2014","mois":"5","numero":"24:3","page":"318-23","auteurs":[{"ID":8690,"post_author":"0","post_date":"2018-12-03 18:02:58","post_date_gmt":"2018-12-03 17:02:58","post_content":"","post_title":"Stacey A Kenfield","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"stacey-a-kenfield","to_ping":"","pinged":"","post_modified":"2018-12-03 18:02:58","post_modified_gmt":"2018-12-03 17:02:58","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/stacey-a-kenfield\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":8691,"post_author":"0","post_date":"2018-12-03 18:02:59","post_date_gmt":"2018-12-03 17:02:59","post_content":"","post_title":"June M Chan","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"june-m-chan","to_ping":"","pinged":"","post_modified":"2018-12-03 18:02:59","post_modified_gmt":"2018-12-03 17:02:59","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/june-m-chan\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":8692,"post_author":"0","post_date":"2018-12-03 18:02:59","post_date_gmt":"2018-12-03 17:02:59","post_content":"","post_title":"Erin L Van Blarigan","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"erin-l-van-blarigan","to_ping":"","pinged":"","post_modified":"2018-12-03 18:02:59","post_modified_gmt":"2018-12-03 17:02:59","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/erin-l-van-blarigan\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"}],"sources":[{"ID":1132,"post_author":"0","post_date":"2018-12-03 15:56:38","post_date_gmt":"2018-12-03 14:56:38","post_content":"","post_title":"Current opinion in urology","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"current-opinion-in-urology","to_ping":"","pinged":"","post_modified":"2018-12-03 15:56:38","post_modified_gmt":"2018-12-03 14:56:38","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/source\/current-opinion-in-urology\/","menu_order":0,"post_type":"source","post_mime_type":"","comment_count":"0","filter":"raw"}]},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v23.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>What should we tell prostate cancer patients about (secondary) prevention? - Aprifel<\/title>\n<meta name=\"description\" content=\"What should we tell prostate cancer patients about (secondary) prevention? - Aprifel\" \/>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"What should we tell prostate cancer patients about (secondary) prevention?\" \/>\n<meta property=\"og:description\" content=\"What should we tell prostate cancer patients about (secondary) prevention?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/\" \/>\n<meta property=\"og:site_name\" content=\"Aprifel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/\",\"url\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/\",\"name\":\"What should we tell prostate cancer patients about (secondary) prevention? - Aprifel\",\"isPartOf\":{\"@id\":\"https:\/\/www.aprifel.com\/fr\/#website\"},\"datePublished\":\"2018-12-04T07:17:58+00:00\",\"dateModified\":\"2018-12-04T07:17:58+00:00\",\"description\":\"What should we tell prostate cancer patients about (secondary) prevention? - Aprifel\",\"breadcrumb\":{\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.aprifel.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9sum\u00e9s\",\"item\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"What should we tell prostate cancer patients about (secondary) prevention?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.aprifel.com\/fr\/#website\",\"url\":\"https:\/\/www.aprifel.com\/fr\/\",\"name\":\"Aprifel\",\"description\":\"Agence pour la Recherche et l\u2019Information en Fruits et L\u00e9gumes\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.aprifel.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"What should we tell prostate cancer patients about (secondary) prevention? - Aprifel","description":"What should we tell prostate cancer patients about (secondary) prevention? - Aprifel","robots":{"index":"noindex","follow":"follow"},"og_locale":"fr_FR","og_type":"article","og_title":"What should we tell prostate cancer patients about (secondary) prevention?","og_description":"What should we tell prostate cancer patients about (secondary) prevention?","og_url":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/","og_site_name":"Aprifel","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/","url":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/","name":"What should we tell prostate cancer patients about (secondary) prevention? - Aprifel","isPartOf":{"@id":"https:\/\/www.aprifel.com\/fr\/#website"},"datePublished":"2018-12-04T07:17:58+00:00","dateModified":"2018-12-04T07:17:58+00:00","description":"What should we tell prostate cancer patients about (secondary) prevention? - Aprifel","breadcrumb":{"@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/what-should-we-tell-prostate-cancer-patients-about-secondary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.aprifel.com\/fr\/"},{"@type":"ListItem","position":2,"name":"R\u00e9sum\u00e9s","item":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/"},{"@type":"ListItem","position":3,"name":"What should we tell prostate cancer patients about (secondary) prevention?"}]},{"@type":"WebSite","@id":"https:\/\/www.aprifel.com\/fr\/#website","url":"https:\/\/www.aprifel.com\/fr\/","name":"Aprifel","description":"Agence pour la Recherche et l\u2019Information en Fruits et L\u00e9gumes","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aprifel.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/resume\/59176"}],"collection":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/resume"}],"about":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/types\/resume"}],"wp:attachment":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/media?parent=59176"}],"wp:term":[{"taxonomy":"mots_cles","embeddable":true,"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/mots_cles?post=59176"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}